In written comments to the FDA, the American Academy of Pain Medicine noted that changing the label on opioid pain medications to limit their continuous use to 90 days would do little to stop drug abuse while depriving millions of Americans the medication they need.
AAPM wrote that adopting the proposal to change the label could eliminate the use of opioids for chronic, non-cancer pain, usually defined as lasting beyond 90 days.
Georgia House Passes Pain Clinic Regulation Legislation
Study: Racial Disparities in Opioid Monitoring, Follow-Up Treatment Practices for Chronic Pain
AAPM wrote that adopting the proposal to change the label could eliminate the use of opioids for chronic, non-cancer pain, usually defined as lasting beyond 90 days.
More Articles on Pain Management:
University of Michigan Appoints Carmen Green as Associate Dean for Health EquityGeorgia House Passes Pain Clinic Regulation Legislation
Study: Racial Disparities in Opioid Monitoring, Follow-Up Treatment Practices for Chronic Pain